BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,840
+1,230 (8.42%)
May 13, 2025, 3:30 PM KST
5.60%
Market Cap 504.47B
Revenue (ttm) 130.05B
Net Income (ttm) -35.07B
Shares Out 31.85M
EPS (ttm) -1,126.45
PE Ratio n/a
Forward PE 45.32
Dividend n/a
Ex-Dividend Date n/a
Volume 458,363
Average Volume 266,094
Open 14,730
Previous Close 14,610
Day's Range 14,730 - 16,000
52-Week Range 12,180 - 27,300
Beta 1.27
RSI 51.37
Earnings Date May 15, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 582
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.